Business & Industry

NovaBay-Pharma-Logo-101912

NovaBay signs distribution agreement with the Biopharm Group

NovaBay Pharmaceuticals, a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, has signed an exclusive distribution agreement for NovaBay’s NeutroPhase Skin and Wound Cleanser with the Biopharm Group, a leading pharmaceutical company in the Middle East, headquartered in Cairo, Egypt. Under the terms of the agreement, Biopharm will market NeutroPhase

IFC extends facility to Nigeria pharmacy chain, HealthPlus

The International Finance Corporation (IFC), a member of the World Bank Group, has announced an agreement with HealthPlus Limited and CasaBella International Limited to provide a $5 million loan facility that will help the two companies expand pharmaceutical and personal care services in Nigeria.

NovaBay-Pharma-Logo-101912

NovaBay signs distribution agreement with the Biopharm Group

NovaBay Pharmaceuticals, a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, has signed an exclusive distribution agreement for NovaBay’s NeutroPhase Skin and Wound Cleanser with the Biopharm Group, a leading pharmaceutical company in the Middle East, headquartered in Cairo, Egypt. Under the terms of the agreement, Biopharm will market NeutroPhase

Deals

Dannex

Dannex acquires majority stake in Starwin

GhanaWeb reports that local pharmaceutical company Dannex has acquired majority stake in Accra, Ghana-based Starwin Products Limited. The acquisition which was made through a rights issue makes Dannex the biggest shareholder of the company with 71.33 percent shares translating to 185,317,279 shares. 333,359,264 ordinary shares of no par value at GHS 0.03 per share in

Policy & Regulatory Affairs

nhis

Ghana: ‘Good governance of pharma sector critical to sustain health insurance scheme’

Ghanaian Minister of Health, Dr. Kweku Agyeman-Mensah, has said the government was committed to put the necessary measures in place to ensure the sustainability of the National Health Insurance Scheme (NHIS). Speaking at a forum  organized by the Medicines Transparency Alliance (MeTA)—a United Kingdom Department for International Development (DfID)-funded initiative to improve sustainable access to medicines

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Arab African Joint Pharmaceutical Market

Pharma Projects

fidson_tour13

Fidson Healthcare to set up new plant

Leading Nigeiran pharmaceutical company, Fidson Healthcare Plc is set to construct a new World Health Organization (WHO)-standard Biotech Plant in the industrial town of Sango Ota, Ogun State.

Plans set for new ARV production plant in Ghana

Oxford International Biomedical Ventures (OIBV), the ‘commercial arm’ of  United Kingdom-based charitable organisation Oxford International Biomedical Centre (OIBC) and the Government of Ghana (GoG) led by the Ministry of Environment, Science and Technology (MEST), are set to jointly establish a plant to manufacture anti-retroviral drugs and drugs for Priority Endemic Diseases in Ghana, OIBC said in a

People

Pharma Deko appoints Non- Executive Director

Pharma Deko Plc has notified the Nigerian Stock Exchange that at the 137th meeting of its Board of Directors held on Wednesday, May 14th 2014, Professor Herbert C.B. Coker of the Faculty of Pharmacy, University of Lagos was appointed a Non–Executive Director of the Company effective May 15, 2014.

Press Releases

Serenus Names Accomplished Group of Researchers to Scientific Advisory Board

SAN FRANCISCO, CA and JOHANNESBURG, SOUTH AFRICA–(Marketwired – Oct 28, 2014) – Serenus Biotherapeutics, Inc., a specialty biopharmaceutical company bridging the divide between the world’s leading pharmaceutical markets and the growing demand for access to innovative therapies in the emerging nations of Sub-Saharan Africa, today announced appointment of a group of accomplished researchers to its

International

Ebola vaccine from Glaxo passes early safety test

An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine. The trial, which began on Sept. 2 and will monitor the volunteers for 48 weeks,

China delegation conducts East African visit and seminar

The Chinese Chamber of Commerce for Import & Export of Medicines and Health Products (CCCMHPIE) last month led a delegation to the East African countries of Kenya and Tanzania from Sep. 13 to 19 during which it held in Kenya a seminar titled “Sino-Africa Drug Trade Cooperation – The Seminar on Chinese Medicinal Products”.

Top
Follow

Get every new post delivered to your Inbox

Join other followers